Companies: 10,795·Total market cap: $144.5T
Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated

PRLDNASDAQHealthcare● Active
$3.99
+$0.15(+3.91%)
Market Cap$227161780
P/E Ratio
52W High$5.54
52W Low$0.75
Overview

Prelude Therapeutics Incorporated(PRLD)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRLD · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($99.50M)($127.17M)($121.83M)($115.44M)($111.69M)
Depreciation & Amort.$1.34M$1.77M$1.17M$1.32M$0.92M
Stock-Based Comp.$11.91M$21.34M$25.62M$25.14M$20.93M
Change in Working Capital$28.41M$4.22M($10.48M)$0.93M$3.63M
Net Cash from Operations($56.30M)($102.89M)($107.06M)($83.73M)($83.53M)
Investing Activities
Capital Expenditure($0.07M)($0.76M)($3.51M)($3.02M)($2.32M)
Purchases of Investments($100.87M)($52.69M)($221.63M)($119.22M)($261.48M)
Sales of Investments$154.39M$143.65M$190.50M$203.93M$0.00M
Net Cash from Investing$53.46M$90.19M($34.65M)$81.69M($263.80M)
Financing Activities
Common Stock Repurchased$0.00M$0.00M$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid($0.21M)($0.40M)$0.00M$0.00M$0.00M
Net Cash from Financing$24.82M($0.12M)$136.40M$0.81M$164.90M
Free Cash Flow
Free Cash Flow($56.37M)($103.65M)($110.58M)($86.75M)($85.85M)
FCF Margin %(computed)-464.32%

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Prelude Therapeutics Incorporated

关于Prelude Therapeutics Incorporated(PRLD)现金流量表

Prelude Therapeutics Incorporated 2025财年经营活动现金流($0.06B),自由现金流($0.06B)(FCF利润率-464.32%),资本支出($0.00B)。

常见问题

PRLD · 4 问

Prelude Therapeutics Incorporated 2025财年自由现金流($0.06B),同比up45.6%。

PRLD free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10